John Cena Reveals Demodex Blepharitis, Backs XDEMVY Ahead of 50

Q: John Cena's promoted 'eye mite' cure is a blockbuster. But what is the out-of-pocket cost for the average patient?

There is no publicly established “average patient” out-of-pocket price for XDEMVY in the material available, and the amount appears to vary widely by insurance coverage. What is clear is that XDEMVY is a prescription drug whose patient cost depends on an individual’s pharmacy benefit, deductible, copay, and prior-authorization status. Tarsus, the drug’s maker, offers support through Tarsus Connect, including insurance verification, coverage assistance, copay programs, and patient-assistance options, which suggests many patients do not pay a standard retail amount. The reporting also points to substantial financial assistance for some users. Separate coverage cited allegations that many Medicare patients rely on copay support through the HealthWell Foundation’s blepharitis fund, with one report claiming about half of Medicare XDEMVY patients use that assistance. If that is the case, out-of-pocket costs for many of those patients could be reduced sharply, potentially to very little, though the exact amount is not stated. So the best answer is that no reliable average dollar figure is provided in the available news and supporting material. For a patient, the real out-of-pocket cost is likely to range from low copays with assistance to much higher amounts without strong insurance coverage. The practical way to find the price is through an insurer, pharmacy, or Tarsus’s patient-support program.

3 articles · Updated · USA TODAY · Jul 16

John Cena said blurry vision, itchiness, redness and eye crust led to an exam that diagnosed Demodex blepharitis, an eyelid inflammation caused by excess eye mites.
Tarsus has enlisted the 17-time WWE world champion to promote XDEMVY, a prescription eye drop designed to target and kill the mites behind the condition.
Cena said he initially dismissed the symptoms as aging, but now urges earlier eye checks after finding treatment improved how his eyes and skin feel.
Next year’s 50th birthday has sharpened his focus on preventive care after a skin cancer scare, two polyps removed at 45 and a hair transplant.